Healthcare and Life Science
CN Bio appoints Dr. Samantha Macro as Chief Financial Officer
Key executive appointment provides extensive financial industry experience as the Company implements ambitious global growth strategy ...
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to announce that a second milestone equity payment has been triggered resulting in an increase in Avacta’s shareholding in AffyXell Therapeutics ("Af...
New horizons for Guardtech Group as international presence continues to grow
Cleanroom construction specialists establishing their brands overseas with string of exciting European projects ...
ELRIG UK appoints Nick Clare to Board as Vendor Strategy Work Group Lead
Cambridge, UK - The European Laboratory Research & Innovation Group (ELRIG) UK announces the appointment of Nick Clare to the ELRIG board. He will chair and lead the Vendor Strategy Work Group to help ensure the vendors’ perspectives and interests are represented within the ELR...
Central Pharma joins CSafe’s global partner network of pharma service providers to expand supply chain solutions for the cell and gene therapy market.
Central Pharma Cell And Gene Therapy writes...we are delighted to announce our strategic CGT partnership with CSafe, in a sector we are deeply passionate about. ...
Epicentre, Haverhill to run “coping with menopausal symptoms” sessions
The EpiCentre at Haverhill is to run a series of 90-minute sessions to help women who struggle with menopausal symptoms. ...
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC)
Pangaea Data awarded strategic partnership by Mersey Care NHS Foundation Trust and the University of Liverpool’s Mental Health Research for Innovation Centre (M-RIC) to characterize patients across hard-to-diagnose mental health conditions. ...
Avacta acquires Coris Bioconcept, adding a broad range of marketed professional-use rapid tests to the Group
Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics. ...
Cresset releases Flare™ V7
Flare™ is a comprehensive drug design platform that integrates the power of ligand and ...
Cellular Origins launches Constellation, its configurable robotic platform to enable scalable manufacture of advanced therapies
Closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labour by 51% and 16-fold respectively Scales cell therapy manufacturing without changing the process used in clin...